demonstrated that GRPR is overexpressed in squamous cell carcinoma of the head and neck (HNSCC), and GRPR was further used as a biomarker for surgical margin prediction in a murine orthotopic model of oral cancer (38). This evidence concerns the gene GRPR and lip and oral cavity carcinoma.